BioXcel Therapeutics Inc. (BTAI) |
|
36.97 13.12 (55.01%)
|
02-14 16:00 |
|
Open: |
38.73 |
Pre. Close: |
23.85 |
|
High:
|
41.51 |
Low:
|
32 |
|
Volume:
|
4,691,882 |
Market Cap:
|
667M |
|
|
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
41.561 - 41.715 |
41.715 - 41.839 |
|
Low:
|
31.671 - 31.825 |
31.825 - 31.948 |
|
Close:
|
36.708 - 36.977 |
36.977 - 37.194 |
|
Technical analysis |
as of: 2020-02-14 4:27:09 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 48.48 One year: 56.63 |
| Support: |
Support1: 23.43 Support2: 12.25 |
| Resistance: |
Resistance1: 41.51 Resistance2: 48.48 |
| Pivot: |
20.25 |
| Moving Average: |
MA(5): 24.47 MA(20): 19.47
MA(100): 9.99 MA(250): 10.03 |
| MACD: |
MACD(12,26): 3.35 Signal(9): 2.24 |
| Stochastic oscillator: |
%K(14,3): 73.32  %D(3): 75.42 |
| RSI: |
RSI(14): 85.23 |
| 52-week: |
High: 41.51 Low: 3.76 Change(%): 318.7 |
| Average Vol(K): |
3-Month: 38168 10-Days: 89159 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.BTAI has closed above the upper band by 35.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 301.3% wider than normal. The large width of the bands suggest high volatility as compared to BTAI's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2020-02-14
The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL ) AtriCure Inc. (NASDAQ: ATRC ) Beam Therapeutics Inc (NASDAQ: BEAM ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) ChemoCentryx Inc (NASDAQ: CCXI ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fortress Biotech (NASDAQ: FBIO ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Masimo Corporation (NASDAQ: MASI ) NeoGenomics, Inc. (NASDAQ: NEO ) Nevro Corp (NYSE: NVRO ) Recro Pharma Inc (NASDAQ: REPH ) ResMed Inc. (NYSE: RMD ) Revolution Medicines Inc (NASDAQ: RVMD ) (went public Thursday) Syneos Health Inc (NASDAQ: SYNH ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Taro Pharmaceutical Industries Ltd. (NYSE: TARO ) West Pharmaceutical Services Inc.
2020-02-13
Stock Alert: BioXcel Therapeutics (BTAI)
BioXcel Therapeutics Inc. (BTAI), which had a banner year in 2019, gaining a whopping 338%, is up an impressive 50% so far this year..
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
